EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nrf2/Nlrp3 signaling in aging BMSCs: Traf6 intervention as a novel approach to osteoporosis treatment

Yajun Li, Yunshang Yang, Donglong Xia, Yiling Fang, Cheng Tang, Jingxian Yu, Dechun Geng, Zhirong Wang, Long Xiao

Redox Biology · 2025

DOI: 10.1016/j.redox.2025.103804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Redox Biology, 2025. Verfasst von Yajun Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Osteoporosis, Mesenchymal Stem Cells, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Nanjing University, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Senile osteoporosis progression is closely related to the decreased osteogenic differentiation capacity of senescent bone marrow stromal stem cells (BMSCs). This study demonstrated that the Traf6-mediated Nrf2/Nlrp3 signaling axis significantly influences inflammatory senescence progression in BMSCs, and targeting Traf6 can effectively alleviate bone loss caused by inflammatory senescence. High-throughput sequencing revealed that primary BMSCs from 18Ms mice were differentially enriched in anti-inflammatory, antioxidant, and immune-related biological processes compared to those from young mice, with significant differences in the protein expression of Traf6, Nrf2, and Nlrp3-related pathways, indicating potential crosstalk. In vitro experiments using western blotting and immunofluorescence confirmed high levels of intracellular inflammation, oxidative stress, and elevated expression of Traf6, Nrf2, and Nlrp3 inflammatory vesicles in senescent BMSCs. We used lentiviral transfection to knockdown Traf6 and intervention with Nrf2 agonists and inhibitors, and we verified the regulation of the expression of Nrf2/Nlrp3 inflammatory vesicles by Traf6 and its effect on inflammatory senescence progression in BMSCs. We performed in vivo experiments involving targeted Traf6 knockdown in bone tissue, morphological analysis of the femur by micro-computed tomography and immunohistochemistry, measurement of serum MDA and bone metabolism-related indices using ELISA, and calcein labeling to observe the calcium salt deposition rate. These experiments confirmed that the Traf6-mediated Nrf2/Nlrp3 signaling axis significantly influences the inflammatory senescence of BMSCs. Targeting Traf6 effectively alleviates bone loss caused by inflammatory senescence, presenting a potential method for preventing and controlling senile osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2OsteoporosisMesenchymal Stem CellsSignal TransductionTNF Receptor-Associated Factor 6NLR Family, Pyrin Domain-Containing 3 ProteinAnimalsMiceCellular SenescenceMaleOsteogenesisHumansOxidative StressDisease Models, Animal

Stichwörter der Autor:innen

Inflammatory senescenceNlrp3 inflammasomeOxidative stressSenile osteoporosisTraf6

Substanzen

NF-E2-Related Factor 2TNF Receptor-Associated Factor 6NLR Family, Pyrin Domain-Containing 3 ProteinNfe2l2 protein, mouseTRAF6 protein, mouseNlrp3 protein, mouse

Autor:innen und Institutionen

  • Translational Medicine Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, China.
  • Department of General Practice, The First People's Hospital of Zhangjiagang, Soochow University, Zhangjiagang, 215600, China.
  • Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. Electronic address: szgengdc@suda.edu.cn.
  • Translational Medicine Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, China. Electronic address: zjgfy_spine_wzr@njucm.edu.cn.
  • Translational Medicine Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, 215600, China. Electronic address: zjgfy_spine_xl@njucm.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Nanjing University
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Science and Technology Program of Suzhou

Zitieren

APA

Li, Y., Yang, Y., Xia, D., Fang, Y., Tang, C., Yu, J., Geng, D., Wang, Z., & Xiao, L. (2025). Nrf2/Nlrp3 signaling in aging BMSCs: Traf6 intervention as a novel approach to osteoporosis treatment. Redox Biology. https://doi.org/10.1016/j.redox.2025.103804

Vancouver

Li Y, Yang Y, Xia D, Fang Y, Tang C, Yu J, et al. Nrf2/Nlrp3 signaling in aging BMSCs: Traf6 intervention as a novel approach to osteoporosis treatment. Redox Biology. 2025. doi:10.1016/j.redox.2025.103804

BibTeX
@article{Li2025,
  author = {Li, Yajun and Yang, Yunshang and Xia, Donglong and Fang, Yiling and Tang, Cheng and Yu, Jingxian and Geng, Dechun and Wang, Zhirong and Xiao, Long},
  title = {Nrf2/Nlrp3 signaling in aging BMSCs: Traf6 intervention as a novel approach to osteoporosis treatment},
  journal = {Redox Biology},
  year = {2025},
  doi = {10.1016/j.redox.2025.103804}
}
Kostenlos starten →